Tag: provides

QIMR Berghofer researchers have developed a way of testing whether or not COVID-19 patients’ immune systems are gearing up to fight the virus that causes the deadly disease. They hope the discovery could be used to identify early on which patients’ immune systems are not responding appropriately, and who might therefore be at higher risk

Recent study by Estonian researchers at the University of Tartu explains how coronavirus is activated before attacking cells and what could help to impede that. The study, published in Scientific Reports, takes us a step closer to understanding why the spread of SARS-CoV-2 has been so rapid and aggressive. The studied virus activation mechanism is

A sophisticated type of artificial intelligence (AI) called deep learning can help rapidly detect blockages in the arteries that supply blood to the head, potentially speeding the onset of life-saving treatment, according to a study published in Radiology. Large vessel occlusions are blockages in the arteries that supply oxygenated blood to the brain. These occlusions

A group of researchers from the University of Toronto have developed a credit-card sized tool for growing cancer cells outside the human body, which they believe will enhance their understanding of breast cancer metastasis. The device, described in a paper published today in Science Advances, reproduces various environments within the human body where breast cancer

Scientists from Trinity College Dublin have made an important discovery that could lead to more effective treatments for people living with multiple sclerosis (MS) and other autoimmune diseases such as psoriasis and rheumatoid arthritis. Their work highlights the significant potential of drugs targeting a specific immune molecule (IL-17) implicated in MS. The scientists, led by

Researchers from King’s have found that a potential treatment for peanut allergy provides some degree of protection but does not cure an allergic patient and this could explain why allergic reactions are still observed during treatment. In the study, published today in the Journal of Allergy and Clinical Immunology, researchers tested samples from patients who

A recent analysis reveals that treatment of male breast cancer has evolved over the years. In addition, certain patient-, tumor-, and treatment-related factors are linked with better survival. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society. Male breast cancer (MBC) comprises one percent of all breast cancer

An early assessment reveals that a newly approved drug to treat migraines does not seem effective among patients who suffer from high-frequency migraines. The findings will be presented this week during the 61st annual scientific meeting of the American Headache Society in Philadelphia. Clinicians at OHSU in Portland, Oregon, conducted a retrospective chart review of

Patients suffering from severe, treatment-resistant depression can benefit not only acutely but also the long term from deep brain stimulation, as researchers from the Medical Center – University of Freiburg and their colleagues from the University Hospital Bonn demonstrate in a current study. The team used thin electrodes to stimulate a deep seated part of

FRIDAY, March 1, 2019 — It may be possible to restore brain cells damaged by Parkinson’s disease and reverse a patient’s condition, something no current treatment can do, according to British researchers who conducted potentially groundbreaking clinical trials. They cautioned the trial was small — just 41 patients — and the research is still in

Research carried out to prove the validity of the new myfood24 online diet monitoring tool has shown it is as effective as similar tools already available to health care practitioners, researchers and educators, and more efficient to use. In 2017, Dietary Assessment Limited was launched as a University of Leeds spin out company to continue

It’s called the Silver Tsunami—the increased incidence of cancer with ageing, combined with the rapidly ageing population means that the Australian health system needs to prepare for an onslaught of cancer diagnoses. A new study out of Monash University, published today in the journal Cell Reports, may have found a group of immune cells that

Further evidence that immunotherapy provides long-term survival benefit for patients with lung cancer was presented today at ELCC 2018 (European Lung Cancer Congress) in Geneva, Switzerland. Researchers presented the three-year survival results of the randomised phase 2 POPLAR trial in second line, which is the longest follow-up reported to date with anti-programmed death ligand 1